Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 325.90 | 382.80 | 398.80 | 463.40 |
| Cost Of Revenue | 116.50 | 137.60 | 147.50 | 168.70 |
| Gross Profit | 209.40 | 245.20 | 251.30 | 294.70 |
| Operating Expense | 204.50 | 213.30 | 198.70 | 272.20 |
| Operating Income | 4.90 | 31.90 | 52.60 | 22.50 |
| EBITDA | 242 | 83.30 | 83.60 | 58.20 |
| EBIT | 182.50 | 38.30 | 55.30 | 27.20 |
| Pretax Income | 158 | -2.90 | 7.50 | -21.60 |
| Tax Provision | 27.20 | 5.30 | 5.30 | 9.10 |
| Net Income | 130.80 | -8.20 | 2.20 | -30.70 |
| Net Income Common Stockholders | 31.80 | -50.20 | -10.50 | -30.70 |
| Total Expenses | 321 | 350.90 | 346.20 | 440.90 |
| Interest Expense | 24.50 | 41.20 | 47.80 | 48.80 |
| Interest Income | 2.70 | 8.20 | 8.50 | 4.60 |
| Selling General And Administration | 145 | 168.30 | 170.40 | 241.20 |
| Normalized EBITDA | 249.90 | 85.80 | 90.90 | 58.20 |
| Normalized Income | 137.34 | -6.22 | 7.97 | -30.70 |
| Basic EPS | 0.46 | -0.78 | -0.07 | -0.15 |
| Diluted EPS | 0.46 | -0.78 | -0.07 | -0.15 |
| Tax Effect Of Unusual Items | -1.36 | -0.53 | -1.53 | 0 |
| Tax Rate For Calcs | 0.17 | 0.21 | 0.21 | 0.21 |
| Total Unusual Items | -7.90 | -2.50 | -7.30 | 0 |
| Total Unusual Items Excluding Goodwill | -7.90 | -2.50 | -7.30 | 0 |
| Net Income From Continuing Operation Net Minority Interest | 130.80 | -8.20 | 2.20 | -30.70 |
| Reconciled Depreciation | 59.50 | 45 | 28.30 | 31 |
| Reconciled Cost Of Revenue | 116.50 | 137.60 | 147.50 | 168.70 |
| Net Interest Income | -21.80 | -35.10 | -39.30 | -44.20 |
| Net Income From Continuing And Discontinued Operation | 130.80 | -8.20 | 2.20 | -30.70 |
| Total Operating Income As Reported | 179.80 | 34.70 | 46.80 | 22.50 |
| Diluted Average Shares | 69.15 | 63.96 | 156.95 | 198.73 |
| Basic Average Shares | 69 | 63.96 | 156.95 | 198.73 |
| Diluted NI Availto Com Stockholders | 31.80 | -50.20 | -10.50 | -30.70 |
| Otherunder Preferred Stock Dividend | 99 | 42 | 12.70 | 0 |
| Net Income Including Noncontrolling Interests | 130.80 | -8.20 | 2.20 | -30.70 |
| Net Income Continuous Operations | 130.80 | -8.20 | 2.20 | -30.70 |
| Other Income Expense | 174.90 | 0.30 | -5.80 | -0.10 |
| Other Non Operating Income Expenses | 182.80 | 2.80 | 1.50 | -0.10 |
| Special Income Charges | -7.90 | -2.50 | -7.30 | 0 |
| Gain On Sale Of Ppe | 0 | -0.20 | 0 | 0 |
| Other Special Charges | 0 | 2.30 | 0 | 0 |
| Impairment Of Capital Assets | 7.90 | 0 | 7.30 | 0 |
| Net Non Operating Interest Income Expense | -21.80 | -35.10 | -39.30 | -44.20 |
| Total Other Finance Cost | 0 | 2.10 | 0 | 0 |
| Interest Expense Non Operating | 24.50 | 41.20 | 47.80 | 48.80 |
| Interest Income Non Operating | 2.70 | 8.20 | 8.50 | 4.60 |
| Other Operating Expenses | -182.80 | -2.80 | -1.50 | 0 |
| Depreciation Amortization Depletion Income Statement | 59.50 | 45 | 28.30 | 31 |
| Depreciation And Amortization In Income Statement | 59.50 | 45 | 28.30 | 31 |
| Operating Revenue | 325.90 | 382.80 | 398.80 | 463.40 |
